Gemici Y.I.Tasci I.2024-07-222024-07-22202118236138http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13474Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect the central nervous system and peripheral nervous system. Major central nervous system manifestations of SARS-CoV-2 infection include seizures, meningoencephalitis, ischemic stroke, anosmia, and hypogeusia. The reversible splenial lesion syndrome was first described in 2004. Although reversible splenial lesion syndrome was initially recognized as a benign phenomenon, a second type of reversible splenial lesion syndrome was identified in later years, which has a poorer prognosis and potentially serious sequela. Reversible splenial lesion syndrome can be caused by numerous etiologies including viruses. In this report, we present a rare case of COVID-19 with reversible splenial lesion, who presented with ataxia and dizziness. © 2021, ASEAN Neurological Association. All rights reserved.EnglishAll Open Access; Bronze Open AccessazithromycinC reactive proteinfavipiravirhydroxychloroquine sulfatelactate dehydrogenaseoseltamiviradultArticleataxiabrain diseasecase reportclinical articlecomputer assisted tomographycoronavirus disease 2019corpus callosumdizzinessDoppler ultrasonographyelectrocardiographyencephalitisfollow upground glass opacityhumanlumbar puncturelung consolidationlymphocyte countlymphocytopeniamagnetic resonance angiographymalemiddle agednuclear magnetic resonance imagingpolymerase chain reactionreversible splenial lesion syndromerisk factorArticle10.54029/2021VMW